NCT06697080Active, not recruiting
Umbilical Cord-derived Mesenchymal Stem Cell Exosomes on Hair Growth in Patients With Androgenetic Alopecia
A Randomized-controlled Clinical Trial to Treat Chinese Advanced AGA With Umbilical Cord-derived Mesenchymal Stem Cell Exosomes
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Active, not recruiting
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Nanfang Hospital, Southern Medical University
- Participants (registry)
- 50
- Start
- June 2024
- Primary completion
- September 2024
- Study completion
- December 2024
- Last registry update
- November 2024
- Countries
- China
Conditions studied: Androgenic Alopecia
Interventions: Human umbilical cord mesenchymal stem cells
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.